| Dr Heath D Canfield, DO | |
|
8669 Kim Ct, Parker, CO 80134-5740 | |
| (303) 408-9337 | |
| Not Available |
| Full Name | Dr Heath D Canfield |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 8669 Kim Ct, Parker, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336295922 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heath D Canfield, DO 8669 Kim Ct, Parker, CO 80134-5740 Ph: (303) 408-9337 | Dr Heath D Canfield, DO 8669 Kim Ct, Parker, CO 80134-5740 Ph: (303) 408-9337 |
News Archive
Ever since World War II, nerve agents have been a concern in modern warfare and up until now, the only antidotes available acted after the agents damaged the nervous system.
Verisk Health, Inc., announced today that Atrius Health has selected Sightlines Medical Intelligence and DxCG Risk Solutions to identify, manage, and predict healthcare risk across its commercial, Medicaid, and Medicare populations.
Presbyterian Intercommunity Hospital (PIH) and Downey Regional Medical Center (DRMC) today announced they had each signed a non-binding letter of intent with plans to execute a definitive agreement calling for PIH's acquisition of DRMC. This will bring together two not-for-profit hospitals both with long standing histories of being dedicated to providing quality care to the communities they serve. The nonbinding letter of intent would allow for the continuation of a nonprofit hospital serving the greater Downey community.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Rivaroxaban has been found to be effective in the prevention of venous thromboembolism (VTE) after orthopedic surgery, for the prevention of stroke in AF (Atrial fibrillation) patients, and as additional therapy to conventional antiplatelet therapy in ACS (Acute coronary syndrome) patients.
› Verified 1 days ago
Ravi C Shah, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9235 Crown Crest Blvd, Suite 200, Parker, CO 80138 Phone: 303-840-5051 Fax: 303-840-5058 | |
Dr. John Robert Tarr, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 19284 E. Cottonwood Drive, Suite 202, Parker, CO 80138 Phone: 720-493-5467 | |
Lionel Thomas, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5869 E Valley Hi Dr, Parker, CO 80138 Phone: 540-750-0778 | |
Jeffrey Keokolo Tamsing, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9235 Crown Crest Blvd, Suite 200, Parker, CO 80138 Phone: 303-840-5051 Fax: 303-840-5058 | |
John Conrad Rudersdorf, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10350 Dransfeldt Rd, Suite 100, Parker, CO 80134 Phone: 303-805-4312 |